UNITED THERAPEUTICS Corp (UTHR) stock
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$584.10−3.78 (-0.64%)
Close on Nov 17, 2026Market cap $25.05BP/E 20.9Yield –
United Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
United Therapeutics's price to sales ratio was 8.1× on Nov 11, 2026, against 6.7× a year earlier. Over the last 5 years it ranged from 4.1× to 8.1×, with a median of 5.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.1× | +1.4 |
| 2025 | Dec 31, 2025 | 6.7× | +1.0 |
| 2024 | Dec 31, 2024 | 5.7× | +1.0 |
| 2023 | Dec 29, 2023 | 4.7× | −2.1 |
| 2022 | Dec 30, 2022 | 6.8× | +0.9 |
| 2021 | Dec 31, 2021 | 5.9× | +1.1 |
| 2020 | Dec 31, 2020 | 4.8× | +2.2 |
| 2019 | Dec 31, 2019 | 2.5× | −0.2 |
| 2018 | Dec 31, 2018 | 2.8× | −1.1 |
| 2017 | Dec 29, 2017 | 3.8× | −0.0 |
| 2016 | Dec 30, 2016 | 3.8× | −1.2 |
| 2015 | Dec 31, 2015 | 5.1× | +0.1 |
| 2014 | Dec 31, 2014 | 5.0× | −0.3 |
| 2013 | Dec 31, 2013 | 5.3× | +2.1 |
| 2012 | Dec 31, 2012 | 3.2× | −0.7 |
| 2011 | Dec 30, 2011 | 3.9× | −2.9 |
| 2010 | Dec 31, 2010 | 6.8× | −1.8 |
| 2009 | Dec 31, 2009 | 8.6× | – |
See a number that looks wrong?